CVR Medical Provides Update
Denver, North Carolina--(Newsfile Corp. - November 9, 2018) - CVR Medical Corp. (TSXV: CVM) (OTCQB: CRRVF) ("CVR Medical") a Canadian listed and US based healthcare company in the medical device sector announces submission of the Carotid Stenotic Scan (CSS) to TUV Rheinland for electrical safety and EMC testing. TUV Rheinland is one of the leading providers of product safety certifications worldwide, covering an assortment of items such as medical devices, home appliances, audio/video...
2018-11-09 9:00 AM EST
Leading Medical Device / Life Science / Healthcare Veteran Joel Kanter Joins Board of Directors of CVR Medical
Denver, North Carolina--(Newsfile Corp. - October 15, 2018) - CVR Medical Corp. (CVM.V) (TSXV: CVM) (OTCQB: CRRVF) ("CVR Medical") a Canadian listed and US based healthcare company in the medical device sector announces that Mr. Joel Kanter has joined the Board of Directors. Mr. Kanter has served as President of Windy City, Inc. a privately held investment firm since July 1986. Mr. Kanter, is a veteran healthcare venture capitalist whose family office has financially backed numerous medical...
2018-10-15 9:00 AM EDT
CVR Medical Shareholders Approve Restructure
Vancouver, British Columbia--(Newsfile Corp. - September 28, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces that on September 26, 2018 the Board of Directors for CVR Medical Corp. (CVM) held a Special Meeting of the Shareholders to approve amongst many things the Restructuring of the Agreement between CVR Medical Corp. and CVR Global Inc. CVR Medical is pleased to report that the Shareholders approved the restructuring as well as all other matters...
2018-09-28 9:09 AM EDT
CVR Medical Announces Proposed Financing
Vancouver, British Columbia--(Newsfile Corp. - August 23, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") a Canadian listed and US based healthcare company in the medical device sector announces that it intends to complete a non-brokered private placement financing (the "Financing") of units (each, a "Unit") for gross proceeds of up to C$2,000,000 with a price per Unit of C$0.30 or such other price determined by CVR Medical management in compliance with TSX...
2018-08-23 9:00 AM EDT
CVR Medical Reports Positive Interim Results from Ongoing Pivotal Trial with CSS Device
Vancouver, British Columbia--(Newsfile Corp. - August 20, 2018) - CVR Medical Corp. (TSXV: CVM) (OTCQB: CRRVF) ("CVR Medical") a Canadian listed and US based healthcare company in the medical device sector announces advisory staff member Dr. Phillip J. Bendick, PhD, has released an internal report summarizing data from the pivotal clinical trials for the Carotid Stenotic Scan (CSS) devices in use at Thomas Jefferson University Hospital. In alignment with the previous report released by Dr....
2018-08-20 9:00 AM EDT
CVR Medical Enlists JD Lymon Group to Provide Reimbursement and Study Design Support
Vancouver, British Columbia--(Newsfile Corp. - August 14, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical"), a Canadian listed and US based healthcare company in the medical device sector, has retained the services of Minneapolis-based medical device consulting firm, JD Lymon Group (www.jdlymon.com), to provide ongoing reimbursement guidance and to help support the company's FDA submission of the Carotid Stenotic Scan (CSS) device for US market clearance by...
2018-08-14 9:00 AM EDT
CVR Medical Retains Global IR/PR Firm ICR To Support Financing and Commercialization Efforts For Its Carotid Stenotic Scan (CSS)
Vancouver, British Columbia--(Newsfile Corp. - August 9, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical"), a Canadian listed and US based healthcare company in the medical device sector, has retained the services of NYC based Investor Relations Public Relations Firm ICR (www.icrinc.com) to support the company's communications and marketing activities as it explores a US National Market listing and advances toward regulatory submission for its Carotid Stenotic...
2018-08-09 9:00 AM EDT
CVR Medical Retains Investment Banking Firm ThinkEquity, A Division of Fordham Financial Management, Inc.
Vancouver, British Columbia--(Newsfile Corp. - June 7, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces it has exclusively retained ThinkEquity, a division of Fordham Financial Management, Inc., a NYC based, investment banking firm to explore listing onto a major exchange in the United States.CVR CSS DeviceTo view an enhanced version of this graphic, please visit:
2018-06-07 8:30 AM EDT
CVR Medical And CVR Global Reach Strategic Agreement
Vancouver, British Columbia--(Newsfile Corp. - May 29, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") has reached agreement with joint venture partner CVR Global to acquire CVR Global's 50% interest in the joint venture and terminate the joint venture (the "Transaction"). The Agreement has been approved by the Board of Directors for both organizations and is now subject to the approval of CVR Medical's shareholders and (inclusive of all proposed share...
2018-05-29 8:30 AM EDT
CVR Medical Retains BUYINS.NET to Surveil Short Sellers and Market Makers
Vancouver, British Columbia--(Newsfile Corp. - May 22, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces it has retained BUYINS.NET, http://www.buyins.net, a leading provider of Regulation SHO compliance monitoring, short sale trading statistics and market integrity surveillance, has initiated coverage on CVR Medical (OTCQB: CRRVF) (TSXV: CVM) (FSE: B3BN) after releasing the latest short sale data through May 17, 2018. The total aggregate number of...
2018-05-22 9:00 AM EDT
CVR Medical Adds Colonel Dallas Hack MD, MPH, MSS, FACMPH, FS, CPE To Board of Directors
Vancouver, British Columbia--(Newsfile Corp. - May 10, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces Colonel Dallas C. Hack, MD, MPH, MSS, FACMPH, FS, CPE has been unanimously appointed to its Board of Directors, replacing Mr. Erwin Wong who is retiring. Colonel Hack is a brain injury expert and is board certified in Preventive Medicine with multiple degrees and certifications including a Master of Public Health and a Master of Strategic Studies....
2018-05-10 9:00 AM EDT
CVR & U.S. FDA: A Meeting of the Minds
Vancouver, British Columbia--(Newsfile Corp. - May 9, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces the receipt of official meeting minutes for their Pre-Submission meeting on March 23, 2018 with the U.S. Food and Drug Administration (FDA) regarding the Carotid Stenotic Scan (CSS) device and it's upcoming FDA submission for market release. Attendees of the meeting included CVR management, regulatory consultant's Duval & Associates, and key...
2018-05-09 9:00 AM EDT
Canon Showcasing Carotid Stenotic Scan (CSS) at NPE the World's Leading Plastic Tradeshow
Vancouver, British Columbia--(Newsfile Corp. - May 7, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical" or "CVR") is pleased to announce that Canon Virginia, Inc. (CVI) will be showcasing our Carotid Stenotic Scan (CSS) at NPE 2018: The Plastics Show, the world's leading plastic tradeshow. Canon Virginia, Inc. (CVI), a wholly owned subsidiary of Canon U.S.A., Inc., provides custom manufacturing solutions, including mold making, injection molding, medical contract...
2018-05-07 1:00 PM EDT
CORRECTION: Tom J. Harris Former CFO at Time Warner Cable And Associated Press Appointed Chief Financial Officer Of CVR Medical
Vancouver, British Columbia--(Newsfile Corp. - May 3, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") has appointed Mr. Tom J. Harris to the position of Chief Financial Officer effective May 1, 2018. As CVR transitions to a sales and marketing focused company, Mr. Erwin Wong retires from his position as CFO. Tom J. Harris will spearhead fiscal preparations while contributing to overall organizational expansions as CVR continues its shift from research and...
2018-05-03 8:53 AM EDT
Tom J. Harris Former CFO at Time Warner Cable And Associated Press Appointed Chief Financial Officer Of CVR Medical
Vancouver, British Columbia--(Newsfile Corp. - May 3, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") has appointed Mr. Tom J. Harris to the position of Chief Financial Officer effective May 1, 2018. As CVR transitions to a sales and marketing focused company, Mr. Erwin Wong retires from his position as CFO. Tom J. Harris will spearhead fiscal preparations while contributing to overall organizational expansions as CVR continues its shift from research and...
2018-05-03 8:30 AM EDT
CVR Medical Bolsters Board Appoints Wayne Hellman Vice-Chairman
Vancouver, British Columbia--(Newsfile Corp. - May 1, 2018) - CVR Medical Corp. (TSXV: CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) ("CVR Medical") is pleased to announce the addition of Mr. Wayne Hellman to its Board of Directors and appointment as Vice Chairman. Mr. Hellman will assume an active role focused on the continued development and upcoming launch of CVR Medical's novel medical device, the "Carotid Stenotic Scan (CSS)." Mr. Hellman's career spans forty years having spent 16 years in...
2018-05-01 8:30 AM EDT
CORRECTION: CVR Medical Announces Temporary Warrant Exercise Price Amendment
The complete and corrected release follows.Vancouver, British Columbia--(Newsfile Corp. - March 19, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN)...
2018-03-19 8:30 AM EDT
CVR Medical Announces Temporary Warrant Exercise Price Amendment
Vancouver, British Columbia--(Newsfile Corp. - March 16, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") today announced that it will temporarily reduce the exercise price of its outstanding 2017 warrants originally issued in February and April 2017 (the "2017 Warrants") from CAD $0.70 (the "Original Exercise Price") to CAD $0.40 (the "Amended Exercise Price") for the period commencing on March 16, 2018 and ending at the close of business on April 6, 2018 (the...
2018-03-16 8:30 AM EDT
Second Trial Data Report: Clinical Substantiation for CVR Medical
Vancouver, British Columbia--(Newsfile Corp. - March 7, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") advisory staff member Dr. Phillip J. Bendick, PhD, has completed his second clinical report summarizing additional data collected from tertiary clinical trials for the Carotid Stenotic Scan (CSS) device. His report confirms the evaluation stated in the prior report, issued in September 2017, which predicted improved accuracy in the ability to identify the...
2018-03-07 8:30 AM EST
CVR Medical Expands Clinical Footprint
Vancouver, British Columbia--(Newsfile Corp. - February 27, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ("CVR Medical") announces Internal Review Board (IRB) approval by The Cleveland Clinic, sanctioning CVR to conduct clinical trials using the Carotid Stenotic Scan (CSS) device. The trial will be overseen by Primary Investigator Dr. Heather Gornik, Medical Director of the Non-Invasive Vascular Laboratory in the Cleveland Clinic Department of Cardiovascular...
2018-02-27 8:30 AM EST